IP Library Granted Patent US 7,519,420
Granted Patent B2
US 7,519,420 · App. 11/470,555 · Granted Apr 14, 2009

Apparatus for selectively destroying dividing cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,519,420
App. No.
11/470,555
Granted
Apr 14, 2009
Kind
B2
Abstract

Dividing cells within living tissue that contain polarizable intracellular members can be destroyed using at least two insulated electrodes and an electric field source that applies an alternating electric potential across the conductors within the insulated electrodes. The electric field is transformed into a non-homogenous electric field that produces an increased density electric field in a region of the dividing cells. The non-homogenous electric field is of sufficient intensity to cause the intracellular members to be drawn to that region, which causes a pressure increase that results in a structural breakdown of the dividing cells.

Claims (26)

1. An apparatus for selectively destroying dividing cells that are in a localized area of living tissue, the dividing cells having polarizable intracellular members, the apparatus comprising:

at least two insulated electrodes with each electrode having an associated conductor and a dielectric material, wherein each of the insulated electrodes (a) is configured for placement against the living tissue and (b) has the dielectric material positioned so as to insulate the conductor from the living tissue; and

an AC voltage source that applies an alternating electric potential across the conductors such that an electric field is induced in the localized area, wherein the electric field in the dividing cells is transformed into a non-homogenous electric field that produces an increased density electric field in a region of the dividing cells, and wherein the non-homogeneous electric field produced within the dividing cells has amplitude and frequency characteristics such that long-term application of the electric field causes the destruction of cells as they divide, but wherein the electric field is sufficiently small so that during long-term application of the electric field, the destruction of the dividing cells is not caused by heat.

2. The apparatus of claim 1 , wherein the electric field is of sufficient frequency so that the non-homogeneous electric field produced in the dividing cells defines electric field lines which generally converge at the region where the electric field has increased density, thereby defining the increased density electric field, resulting in destruction of the dividing cells as a result of the polarizable intracellular members movement toward a cleavage furrow of the dividing cells.

3. The apparatus of claim 1 , further including: at least two conductive leads operatively connecting the at least two insulated electrodes to the electric field source.

4. The apparatus of claim 1 , wherein at least one of the insulated electrodes includes a first dielectric member that is in contact with a first conductor, the first dielectric member configured for placement against the living tissue to form a capacitor.

5. The apparatus of claim 4 , wherein each of the insulated electrodes includes a dielectric member that is in contact with a conductor, the dielectric member configured for placement against the living tissue to form a capacitor.

6. The apparatus of claim 5 , wherein each of the dielectric members is formed of a layer of titanium dioxide.

7. The apparatus of claim 5 , wherein each of the dielectric members comprises a dielectric coating having a thickness between about 5 microns to about 50 microns.

8. The apparatus of claim 7 , further including: a loose net disposed around the dielectric coating for restricting access to a surface of the dielectric coating while only having a minimal effect on a surface area of the dielectric coating.

9. The apparatus of claim 7 , further including: a thin conducting coating disposed on the dielectric coating for contacting the tissue.

10. The apparatus of claim 9 , wherein the conducting coating is formed of gold.

11. The apparatus of claim 5 , wherein the at least two insulated electrodes each includes an intervening filler disposed on the respective dielectric member thereof, the intervening filler being formed of a material that has high conductance and a high dielectric constant.

12. The apparatus of claim 11 , wherein the intervening filler comprises a gel formed of at least one material selected from the group consisting of gelatins and agar.

13. The apparatus of claim 12 , wherein the gel includes salt dissolved therein to increase the conductivity of the gel.

14. The apparatus of claim 11 , wherein the intervening filler is contained within the dielectric member by a rim formed as part of the dielectric member.

15. The apparatus of claim 1 , wherein the alternating electric potential has a frequency of between about 50 kHz to about 500 kHz.

16. The apparatus of claim 1 , wherein the alternating electric potential has a frequency of between about 100 kHz to about 300 kHz.

17. The apparatus of claim 1 , wherein the electric field is a substantially uniform electric field prior to passing through the dividing cells.

18. The apparatus of claim 1 , wherein the electric field source comprises a generator that generates an alternating voltage waveform at frequencies between about 50 kHz to about 500 kHz.

19. The apparatus of claim 18 , wherein each of the at least two insulated electrodes are activated by the alternating voltage waveform.

20. The apparatus of claim 18 , wherein the voltage waveform is selected so that an electric field intensity in tissue to be treated is between about 0.1 V/cm to about 10 V/cm.

21. The apparatus of claim 1 , further including: a control box operatively connected to the electric field source; and a temperature sensor coupled to the control box, wherein the control box and the temperature sensor control the amplitude of the electric field generated so that excessive heating in a treated area is prevented.

22. The apparatus of claim 1 , wherein the at least two insulated electrodes are internal members that are inserted within the body.

23. The apparatus of claim 22 , wherein the at least two insulated electrodes are incorporated into a structure that is inserted subcutaneously within the body.

24. The apparatus of claim 1 , wherein the at least two insulated electrodes are configured for placement on opposite sides of a torso with the dividing cells being associated with a tumor that is formed within the body at a location between the at least two insulated electrodes.

Assignments (18)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 45278 0825 Recorded Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 50395/0398 Recorded Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825 Recorded Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
RELEASE OF SECURITY INTEREST Recorded Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
SECURITY INTEREST Recorded May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
SECURITY INTEREST Recorded Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2014
From: PALTI, YORAM
To: STANDEN LTD.
Reel/Frame 034549/0406 →
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2013
From: DEUTSCHE BANK TRUST COMPANY AMERICAS
To: NOVOCURE LIMITED
Reel/Frame 031866/0567 →
SECURITY AGREEMENT Recorded Feb 20, 2013
From: NOVOCURE LIMITED
To: DEUTSCHE BANK TRUST COMPANY AMERICAS
Reel/Frame 029845/0135 →
CHANGE OF NAME Recorded May 19, 2011
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 026311/0210 →